Get started
Author

Lucía Daniela Grippo

Observed names: Lucia D. Grippo, Lucia Grippo
ORCID: 0000-0002-0058-9279
Observed ORCID: 0000-0002-0058-9279
OpenAlex ID: A5063786045
A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model training
2025 · Ammar Arsiwala, Rebecca Bhatt, et al. · mAbs · 24
2025 Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data standardization
2026 · Lood van Niekerk, Joshua Moller, et al. · mAbs · 11
Gemini lipopeptides as vaccine adjuvants: a new role for these versatile carriers
2020 · Lucía Daniela Grippo, Ivana Gabriela Reidel, et al. · Clinical and Experimental Vaccine Research · 4
PDF
Decoding Bispecific Antibody Developability: Design Rules and Predictive Models from a 160-Member Library
2026 · Seth Ritter, Laura Rand, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Activity-Structure Study on the Peptide Fraction of AG2: a Potent In Vitro Transfection Agent
2019 · Lucia D. Grippo, Juan M. Rudi, et al. · Applied Biochemistry and Biotechnology · 2
Predicting VHH-Fc Developability from Large-Scale IgG Data
2026 · Joshua Moller, Seth Ritter, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Works count: 6
Citation count: 43
H-index: 3
I10-index: 2
Year
Topic
Type